BlackRock still buying the Ebos dip
BlackRock continues to dip in and out of Ebos Group as the healthcare products maker trades at a cheaper price since losing the lucrative Chemist Warehouse supply deal in Australia. The international investment manager first appeared as a substantial holder of Ebos shares on June 6 with a 5% stake, or 9.6 million shares worth about $397.5m, or $41.46 per share, building up its stake over the previous three months since the healthcare products company was set to be added to the S&P/ASX 300 index.Since then, BlackRock has hovered above a...
Subscribe to BusinessDesk
Stay informed on business, government and financial developments across New Zealand.
- Stay informed on business, government and financial developments across New Zealand.
- Deeply researched, twice-edited and fact-checked news
- Annual subscribers also receive a complimentary subscription to The Wall Street Journal
- Personalised email news alerts, plus gift up to 5 stories a month to non-subscribers
You can cancel anytime with two clicks, an email or a phone call.
Find out
more.
We are serious about journalism.
Or use the information you’ve already given Google to create your subscription.
Not convinced yet?
Subscribe to our free 7am Headlines newsletter.
A quick summary of everything BusinessDesk has published in the previous 24 hours. No BusinessDesk
subscription needed.